BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,079 filers reported holding BAXTER INTL INC in Q3 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $186 | +100.0% | 4,925 | +140.2% | 0.07% | +69.8% |
| Q2 2023 | $93 | +12.0% | 2,050 | 0.0% | 0.04% | +4.9% |
| Q1 2023 | $83 | -20.2% | 2,050 | 0.0% | 0.04% | -24.1% |
| Q4 2022 | $104 | -99.9% | 2,050 | 0.0% | 0.05% | -14.3% |
| Q3 2022 | $110,000 | -16.7% | 2,050 | 0.0% | 0.06% | -11.3% |
| Q2 2022 | $132,000 | -17.0% | 2,050 | 0.0% | 0.07% | -4.1% |
| Q1 2022 | $159,000 | -9.7% | 2,050 | 0.0% | 0.07% | -8.6% |
| Q4 2021 | $176,000 | +6.7% | 2,050 | 0.0% | 0.08% | -3.6% |
| Q3 2021 | $165,000 | 0.0% | 2,050 | 0.0% | 0.08% | +2.4% |
| Q2 2021 | $165,000 | -4.6% | 2,050 | 0.0% | 0.08% | -8.9% |
| Q1 2021 | $173,000 | +5.5% | 2,050 | 0.0% | 0.09% | -2.2% |
| Q4 2020 | $164,000 | -0.6% | 2,050 | 0.0% | 0.09% | -8.0% |
| Q3 2020 | $165,000 | -6.8% | 2,050 | 0.0% | 0.10% | -10.7% |
| Q2 2020 | $177,000 | +6.6% | 2,050 | 0.0% | 0.11% | -5.9% |
| Q1 2020 | $166,000 | -2.9% | 2,050 | 0.0% | 0.12% | +20.2% |
| Q4 2019 | $171,000 | -4.5% | 2,050 | 0.0% | 0.10% | -10.0% |
| Q3 2019 | $179,000 | +6.5% | 2,050 | 0.0% | 0.11% | +7.8% |
| Q2 2019 | $168,000 | +0.6% | 2,050 | 0.0% | 0.10% | -1.0% |
| Q1 2019 | $167,000 | -0.6% | 2,050 | -19.6% | 0.10% | -6.4% |
| Q4 2018 | $168,000 | -14.7% | 2,550 | 0.0% | 0.11% | 0.0% |
| Q3 2018 | $197,000 | +4.8% | 2,550 | 0.0% | 0.11% | +3.8% |
| Q2 2018 | $188,000 | +11.9% | 2,550 | -3.8% | 0.11% | +6.0% |
| Q1 2018 | $168,000 | -1.8% | 2,650 | 0.0% | 0.10% | -20.0% |
| Q4 2017 | $171,000 | +3.0% | 2,650 | 0.0% | 0.12% | -3.8% |
| Q3 2017 | $166,000 | +3.8% | 2,650 | 0.0% | 0.13% | +3.2% |
| Q2 2017 | $160,000 | +16.8% | 2,650 | 0.0% | 0.13% | +12.5% |
| Q1 2017 | $137,000 | +16.1% | 2,650 | 0.0% | 0.11% | +9.8% |
| Q4 2016 | $118,000 | -15.7% | 2,650 | -10.2% | 0.10% | -18.4% |
| Q3 2016 | $140,000 | +5.3% | 2,950 | 0.0% | 0.12% | +3.3% |
| Q2 2016 | $133,000 | +9.9% | 2,950 | 0.0% | 0.12% | +7.1% |
| Q1 2016 | $121,000 | -5.5% | 2,950 | -11.9% | 0.11% | -5.0% |
| Q4 2015 | $128,000 | +7.6% | 3,350 | -8.2% | 0.12% | +5.3% |
| Q3 2015 | $119,000 | -53.3% | 3,650 | 0.0% | 0.11% | -50.7% |
| Q2 2015 | $255,000 | +2.0% | 3,650 | 0.0% | 0.23% | +6.0% |
| Q1 2015 | $250,000 | -6.7% | 3,650 | 0.0% | 0.22% | -6.5% |
| Q4 2014 | $268,000 | -99.9% | 3,650 | 0.0% | 0.23% | -6.5% |
| Q3 2014 | $261,960,000 | -0.7% | 3,650 | 0.0% | 0.25% | +3.8% |
| Q2 2014 | $263,895,000 | -1.7% | 3,650 | 0.0% | 0.24% | -5.6% |
| Q1 2014 | $268,567,000 | +5.8% | 3,650 | 0.0% | 0.25% | +5.0% |
| Q4 2013 | $253,858,000 | +5.9% | 3,650 | 0.0% | 0.24% | 0.0% |
| Q3 2013 | $239,768,000 | -5.2% | 3,650 | 0.0% | 0.24% | -10.4% |
| Q2 2013 | $252,836,000 | – | 3,650 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |